Form 4: Humacyte Director Exercises Stock Options and Disposes of Shares
SEC Form 4 Filing
Charles Bruce Green, a director of Humacyte, Inc., exercised stock options and disposed of 1,200 shares of common stock on September 13, 2024.
Summary
- On September 13, 2024, Charles Bruce Green, a director of Humacyte, Inc., executed transactions involving the company's stock.
- Green exercised stock options to acquire 1,200 shares of common stock at a price of $4.09 per share.
- Simultaneously, Green disposed of 1,200 shares.
- Following these transactions, Green directly owns 10,600 stock options and 2,400 shares of Humacyte common stock.
Sentiment
Score: 5
Explanation: This is a neutral event. It's a standard disclosure of insider trading activity, with no inherent positive or negative implications.
Industry Context
This filing is a routine disclosure of insider transactions, which are common in publicly traded companies. It provides transparency into the trading activities of company directors.
Stakeholder Impact
- The transaction may have a minor impact on shareholders due to the change in ownership, but it is unlikely to be significant.
Key Dates
| Date | Description |
|---|---|
| 09/15/2023 | Date exercisable for stock options |
| 09/13/2024 | Date of transaction: stock options exercised and shares disposed of. |
| 09/15/2032 | Expiration date for stock options |
| 09/16/2024 | Date of signature for the report. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.